ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 709237 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 709237; 2) Community: the network communities that were significantly associated with the response to NSC 709237; 3) Molecule: the relationships between components within communities and NSC 709237; 4) MDR: the compounds that were significantly associated with the NSC 709237.

NSC Compound Enrichment Correlation
NSC 610458 Camptothecin Derivative 0.00112942993514741 0.81561451
NSC 639174 Camptothecin Derivative 0.00112942993514741 0.86286718
NSC 639186 Raltitrexed 0.00112942993514741 0.5044896
NSC 658247 Pyridine-3,5-dicarboxylic acid, 1,4-dihydro-2,6-dimethyl-, bis[2-(2-hydroxybenzoyl)hydrazide] 0.00112942993514741 0.33868091
NSC 681635 Camptothecin Derivative 0.00112942993514741 0.87766461
NSC 734235 isoindolo[1,2-a]quinoxalin-4(5H)-one 0.00137859316241635 -0.0058485283
NSC 693167 Null 0.00138064329694955 0.45246872
NSC 733882 6-(3-Azidopropyl)-5,6-dihydro-9-methoxy-3-nitro-5,11-dioxo-1 1H-indeno[1,2-c]isoquinoline 0.00138064329694955 0.69095033
NSC 725671 5,6-Dihydro-5,11-dioxo-6-(3-amino-1-propyl)-11H-indeno[1,2-c ]isoquinoline hydrochloride 0.00181889981954877 0.47960087
NSC 626880 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-hydroxy- phenyl)methylene]-, hydrochloride 0.00181889981954878 0.00086691586
Total:73  Current:4    [First] [Prev] [Next] [Last]